Lifeboat Foundation

Multiple prominent government ministries in Colombia are responding to a ransomware attack that is forcing officials to make significant operational changes.

This week, the Ministry of Health and Social Protection, the country’s Judiciary Branch and the Superintendency of Industry and Commerce announced that a cyberattack on technology provider IFX Networks Colombia had caused a range of problems limiting the ability of both departments to function.

On Wednesday, the Ministry of Health and Social Protection said it began facing issues on Tuesday after IFX Networks told them of problems affecting their data center.

Zhiling Guo, a Research Fellow at the University of Birmingham outlines research into how nanomaterials found in consumer and health-care products can pass from the bloodstream to the brain side of a blood-brain barrier model with varying ease depending on their shape. A new study reveals that this may create potential neurological impacts that could be both positive and negative.

https://www.birmingham.ac.uk/news/latest/2021/07/nanomateria…study.aspx

Even when a bone marrow transplant cures leukemia or lymphoma, GVHD—in which T cells in the donor graft attack the recipient’s own tissues—can still be fatal. The condition is among the leading causes of death and long-term adverse health consequences associated with bone marrow transplants.

Senior co-corresponding authors Ivan Maillard, MD, PhD, a professor of Medicine and vice chief for research in Hematology-Oncology at the Perelman School of Medicine at the University of Pennsylvania, and Leslie S. Kean, MD, PhD, a professor of Pediatrics at Harvard Medical School and director of Pediatric Stem Cell Transplant at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, along with… More.

In new preclinical research, an experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease in the intestines, without causing broad immune suppression, paving the way for clinical trials.

Continue reading “Antibody Prevents Graft Versus Host Disease in Preclinical Tests” »

Human intervention right now holds the key.

How do we assess the health of our planet? In 2009, a group of 28 scientists wanted a definite answer to this question. So, they outlined nine planetary boundaries, which are critical for Earth’s stability.

A reassessment in 2023 says that six of these nine planetary boundaries have been transgressed, suggesting that Earth is “well outside of the safe operating space for humanity.”

The threat group behind the fast-growing Rhysida ransomware-as-a-service operation has claimed credit for an Aug. 19 attack that crippled systems at Singing River Health System, one of Mississippi’s largest healthcare entities.

The attack follows one against California’s Prospect Medical Holdings in August that affected 16 hospitals and more than 160 clinics around the country. The wide scope of that incident prompted an alert from the Health Sector Cybersecurity Coordination Center to other organizations in the industry.

The attack on Singing River impacted three hospitals and some 10 clinics belonging to the system and is likely to reinforce Rhysida’s credentials as a growing threat to healthcare organizations in the US. It’s also a reminder of the surging interest in the sector from ransomware actors who, early in the COVID-19 pandemic, had piously vowed to stay away from attacking hospitals and other healthcare entities.

Quantum computing has the potential to revolutionize the world, allowing massive health and science computation problems to be solved exponentially faster than by classic computing. But quantum computers have a big drawback—they can only operate in subzero temperatures.

“In order to make quantum computers work, we cannot use them at room temperature,” said Ahmed El-Gendy, Ph.D., an associate professor of physics at The University of Texas at El Paso. “That means we will need to cool the computers and cool all the materials, which is very expensive.”

Now, physicists at The University of Texas at El Paso believe they have made a quantum leap in that regard. Led by El-Gendy, the team has developed a highly magnetic quantum computing material—100 times more magnetic than pure iron—that functions at regular temperature. The material is described in a summer issue of the journal Applied Physics Letters.

Researchers have shown that high concentrations of key proteins in human breast milk, especially osteopontin and κ-casein, are associated with a greater abundance of two species of bacteria in the gut of babies: Clostridium butyricum and Parabacteroides distasonis, known to be beneficial for human health and used as probiotics. These results suggest that proteins in breast milk influence the abundance of beneficial gut microbes in infants, playing an important role in early immune and metabolic development

More than 320 million years of mammalian evolution has adapted breast milk to meet all the physiological needs of babies: it contains not only nutrients, but also hormones, antimicrobials, digestive enzymes, and growth factors. Furthermore, many of the proteins in breast milk, for example casein and milk fat globule membrane proteins, aren’t just sources of energy and molecular building blocks, but also directly stimulate immunity, at least under preclinical conditions.

The innovation – which has undergone advanced pre-clinical trials – is effective against a broad range of drug-resistant bacterial cells, including ‘golden staph’, which are commonly referred to as superbugs.

Antibiotic resistance is a major global health threat, causing about 700,000 deaths annually, a figure which could rise to 10 million deaths a year by 2050 without the development of new antibacterial therapies.

The new study led by RMIT University and the University of South Australia (UniSA) tested black phosphorus-based nanotechnology as an advanced infection treatment and wound healing therapeutic.

Continue reading “Ultrathin nanotech promises to help tackle antibiotic resistance” »

Netherlands: The use of proton pump inhibitors (PPI) among kidney transplant recipients may lead to severe fatigue, fatigue severity, and lower mental and physical health-related quality of life, a new study has suggested. The study was published online in the American Journal Of Kidney Diseases.

Proton pump inhibitors (PPIs) are commonly prescribed medications for the management of acid-related gastrointestinal disorders.

Tim J. Knobbe and colleagues aimed to investigate the potential association between PPI use and fatigue as well as health-related quality of life among 937 kidney transplant recipients. Participants were at least one-year post-transplantation and were enrolled in the TransplantLines Biobank and Cohort Study.